Page 2 - Pharma Sctors

Moderna slump hits 50% from peak, erasing $98 billion value

Moderna's shares were pressured as coronavirus pills by Pfizer and Merck & Co recently received FDA authorisation

Adar Poonawalla picks up 20% stake in social media platform Wakau

Wakau offers a combination of mobile-first screen experience and short video content in entertainment and fashion domains

Moderna's booster raises antibody levels by 80 times against Omicron

The company said a two-dose course of its vaccine generated low neutralising antibodies against the Omicron variant

Drugmaker Biogen cuts the price tag on its Alzheimer's medicine in half

Biogen said that it will cut the wholesale acquisition cost of the drug by about 50 per cent next month

Natco board approves proposal to acquire US-based pharma company

The company's board has approved to acquire Dash Pharmaceuticals through one of its subsidiary units, it said

AstraZeneca blocks Advent's $7.6-bn buyout of Swedish Orphan Biovitrum

The UK drugmaker's opposition meant the offer fell short of the 90 per cent threshold needed for approval

Pharma stocks rally on buzz about new Covid variant, travel stocks sink

Huge gains for Cipla, Alkem Labs and Dr Lal Path, even as IndiGo, Chalet Hotels and IHC tank

BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%

The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.

Cabinet secy-led panel to take call on more allocation to PLI pharma

The department has urged the top government panel to provide additional funds of around Rs 3,000 crore under the scheme for pharmaceutical medicines

Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore

The drug firm on Monday reported a decline in its consolidated net profit

This SME pharma stock has zoomed 108% thus far in September

In past three months, Kwality Pharmaceuticals has zoomed 398 per cent, as compared to 12.8 per cent rise in the S&P BSE Sensex on the back of improved business outlook

ACC, Cipla: 66 stocks from Nifty 500 index are showing weakness on charts

Few pharma stocks are expected to weaken at higher levels.

Alembic Pharma sees domestic business growing in double digits this fiscal

Strong brand recall, an efficient sales force, a growing network of supportive doctors and timely product launches are the key catalysts for this business

Fortis Malar, Lal Path Labs: Diagnostic and healthcare stocks on the charts

Stocks of diagnostic chains and hospitals have been in focus as Covid-19 pandemic spread across the country. Is it a good strategy to stay put in these counters? Here's what the charts suggest

India may face shortage of drugs as supplies from Chinese companies dry up

Almost 60% of India's total bulk drug requirements are imported from China